Research & News Articles

Contact us if you’d like a copy of any of these articles…

Pharmacist Interest and Attitudes

  • DiPietro Mager NA. Fulfilling an unmet need: roles for clinical pharmacists in preconception care. Pharmacotherapy. 2016;36(2):141-151. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26846305
  • DiPietro NA, Bright DR. Medication therapy management and preconception care: opportunities for pharmacist intervention. Innovations in Pharmacy. 2014;5(1):1-9. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27838391
  • El-Ibiary SY, Raney EC, Moos MK. The pharmacist’s role in promoting preconception health. J Am Pharm Assoc. 2014;54(5):e288-e303. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25107285
  • Hilverding AT, DiPietro NA. Pharmacists’ attitudes regarding provision of sexual and reproductive health services. JAMA. 2017;57(40): 493-497. Available at: https://www.ncbi.nlm.nih.gov/pubmed/28619391
  • Hohmann N, Kavookjian J. Using the Theory of Planned Behavior to determine pharmacy students’ intention to participate in hormonal contraception counseling services. Curr Pharm Teach Learn. 2018;10(11):1488-1495. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30514539
  • Landau S, Besinque K, Chung F, et al. Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. J Am Pharm Assoc 2009;49(1):43-50. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19196596
  • Lio I, Remines J, Nadpara PA, et al. Pharmacists’ comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy. J Am Pharm Assoc. 2018;58:S89-S93. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30006191
  • McIntosh J, Rafie S, Wasik M, McBane S, Lodise NM, El-Ibiary SY, et al. Changing oral contraceptives from prescription to over-the-counter status: An opinion statement of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31(4):424-37. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21449630
  • Ng C, Najjar R, DiPietro Mager N, Rafie S. Pharmacist and student pharmacist perspectives on providing preconception care in the United States. J Am Pharm Assoc. 2018. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29884475
  • Rafie S, Cieri-Hutcherson NE, Frame TR, et al. Pharmacists’ perspectives on prescribing and expanding access to hormonal contraception in pharmacies in the United States. J Pharm Pract 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31390938
  • Rafie S, McIntosh J, Shealy KM, et al. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2014;34(9):991-9. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24989020
  • Rafie S, Richards E, Rafie S, Landau SC, Wilkinson TA. Pharmacist outlooks on prescribing hormonal contraception following statewide scope of practice expansion. Pharmacy 2019;7(3). Available at: https://www.mdpi.com/2226-4787/7/3/96
  • Rafie S, Stone RH, Wilkinson TA, Borgelt LM, El-Ibiary SY, Ragland D. Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects. Integr Pharm Res Pract. 2017;6:99-108. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29354556
  • Rodriguez MI, McConnell KJ, Swartz J, Edelman AB. Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision. J Am Pharm Assoc 2016;56(5):521-6. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27594105
  • Vu K, Rafie S, Grindlay K, Gutierrez H, Grossman D. Pharmacist intentions to prescribe hormonal contraception following new legislative authority in California. J Pharm Pract. 2019;32(1):54-61. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29096570

Provider and Consumer Interest and Attitudes

  • Grossman D, Grindlay K, Li R, Potter JE, et al. Interest in over-the-counter access to oral contraceptives among women in the United States. Contraception. 2013;88(4):544-52. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23664627
  • Landau SC, Tapias MP, McGhee B. Birth control within reach: a national survey on women’s attitudes toward and interest in pharmacy access to hormonal contraception. Contraception 2006;74(6):463-70. Available at: https://www.ncbi.nlm.nih.gov/pubmed/17157103
  • Rafie S, Haycock M, Yen S, Harper CC. Direct pharmacy access to hormonal contraception: California physician and advanced practice clinician views. Contraception. 2012;86(6):687-93. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22717185
  • Rafie S, Kelly S, Gray EK, et al. Provider opinions regarding expanding access to hormonal contraception in pharmacies. Womens Health Issues. 2016;26(2):153-60. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26549241
  • Wilkinson TA, Miller C, Rafie S, Laudau SC. Older teen attitudes toward birth control access in pharmacies: a qualitative study. Contraception. 2018;97(3):249-255. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29223497

Training

  • Anderson L, Borgelt LM, Clark P, Moore G. Encouraging comprehensive and consistent pharmacist education for provision of contraception. J Am Pharm Assoc. 2018;58(1):113-116. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29290339
  • Lynch SE, Griffin BL, Vest KM. Assessment of a simulated contraceptive prescribing activity for pharmacy students. Curr Pharm Teach Learn. 2018;10(2):178-184. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29706273
  • Stone RH, Rafie S, Griffin B, Shealy K, Stein AB. Pharmacist self-perception of readiness to prescribe hormonal contraception and additional training needs. Curr Pharm Teach Learn 2020;12(1):27-34. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31843161

Implementation and Experiences

  • Batra P, Rafie S, Zhang Z, et al. An evaluation of the implementation of pharmacist-prescribed hormonal contraceptives in California. Obstet Gynecol 2018;131(5):850-5. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29630024
  • Frost TP, Klepser DG, Small DC, Doyle IC. Time and motion study of pharmacist prescribing of oral hormonal contraceptives in Oregon community pharmacies. J Am Pharm Assoc. 2019 https://www.ncbi.nlm.nih.gov/pubmed/30745187
  • Gardner JS, Miller L, Downing DF, Le S, Blough D, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study.  J Am Pharm Assoc. 2008;48(2):212-21; 5 p following 221. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18359734
  • Gomez AM. Availability of Pharmacist-Prescribed Contraception in California, 2017. JAMA 2017;318(22):2253-2254. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29234797
  • Gomez AM, McCullough C, Hoff C. Expectations of future provision of pharmacist-prescribed hormonal contraception in California. Am J Obstet Gynecol. 2018;218(6):627-628. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29474845
  • Lu S, Rafie S, Jamper J, Strauss R, Kroon L. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies. Contraception. 2018. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30562478
  • Mody SK, Rafie S, Hildebrand M, Oakley LP. Exploring emergency contraception prescribing by pharmacists in California. Contraception 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31493380
  • Rodriguez MI, Anderson L, Edelman AB. Pharmacists begin prescribing hormonal contraception in Oregon: Implementation of House Bill 2879. Obstet Gynecol. 2016;128(1):168-70. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917426/
  • Rodriguez MI, Biel FM, Swartz JJ, Anderson L, Edelman AB. Pharmacists’ experience with prescribing hormonal contraception in Oregon. J Am Pharm Assoc 2018;58(6):608-613. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30190201
  • Wilkinson TA, Rafie S, Clark PD, Carroll AE, Miller E. Evaluating community pharmacy responses about levonorgestrel emergency contraception by mystery caller characteristics. J Adolesc Health 2018;63(1):32-36. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29475729

Outcomes and Cost Savings

  • Rodriguez MI, Darney BG, Edelman AB, Yee K, Anderson LB, McConnell KJ. Pharmacists expand access to reproductive heaLthcare: PEARL study protocol. BMC Health Serv Res 2019;19(1):207. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30935394
  • Anderson L, Hartung DM, Middleton L, Rodriguez MI. Pharmacist provision of hormonal contraception in the Oregon Medicaid population. Obstet Gynecol 2019;133(6):1231-7. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31135739
  • Rodriguez MI, Hersh A, Anderson LB, Hartung DM, Edelman AB. Association of pharmacist prescription of hormonal contraception with unintended pregnancies and Medicaid costs. Obstet Gynecol 2019;133(6):1238-46. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31135740

Reviews and Commentaries

  • Buckingham P, Amos N, Hussainy SY, Mazza D. Scoping review of pharmacy-based initiatives for preventing unintended pregnancy: protocol. BMJ Open. 2020;10(1). Available at: https://www.ncbi.nlm.nih.gov/pubmed/32014873
  • Downing D. Inviting the pharmacist: a model for improved reproductive care access. Contraception 2012;85(1):2-4. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22070991
  • Farris KB, Ashwood D, McIntosh J, DiPietro NA, Maderas NM, Landau SC, Swegle J, Solemani O. Preventing unintended pregnancy: pharmacists’ roles in practice and policy via partnerships. J Am Pharm Assoc 2010;50(5):604-12. Available at: https://www.ncbi.nlm.nih.gov/pubmed/20833619
  • Maderas NM, Landau SC, Taylor-McGhee B. The continuum of care: a case for pharmacists as key members of the reproductive health care team. Contraception 2008;77(3):139-42. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18279681
  • Mospan CM. Pharmacists as women’s health providers: Increasing access to contraception and preconception care. J Am Pharm Assoc 2019;59(5):613-4. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31422025 
  • Rafie S, Landau S. Opening New Doors to Birth Control: State Efforts to Expand Access to Contraception in Community Pharmacies. Birth Control Pharmacist, 2019. Available at: https://birthcontrolpharmacist.com/report.
  • Tak CR, Kessler LT, Scott MA, Gunning KM. Pharmacist-prescribed hormonal contraception: A review of the current landscape. J Am Pharm Assoc 2019;59(5):633-41. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31300307
  • Williams RL, Meredith AH, Ott MA. Expanding adolescent access to hormonal contraception: an update on over-the-counter, pharmacist prescribing, and web-based telehealth approaches. 2018. Curr Opin Obstet Gynecol. 2018;30(6):458-464. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30299318
  • Yang YT, Kozhimannil KB, Snowden JM. Pharmacist-Prescribed Birth Control in Oregon and Other States. JAMA. 2016;315(15):1567–1568. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27019133

News Articles